{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:00:42Z","timestamp":1788883242525,"version":"build-2803163510"},"reference-count":154,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5K08DK124685-03"],"award-info":[{"award-number":["5K08DK124685-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Kidney diseases represent a major public health problem, affecting millions of people worldwide. Moreover, the treatment of kidney diseases is burdened by the problematic effects of conventional drug delivery, such as systemic drug toxicity, rapid drug clearance, and the absence of precise targeting of the kidney. Although the use of nanotechnology in medicine is in its early stage and lacks robust translational studies, nanomedicines have already shown great promise as novel drug-delivery systems for the treatment of kidney disease. On the basis of our current knowledge of renal anatomy and physiology, pathophysiology of kidney diseases, and physicochemical characteristics of nanoparticles, an expansive repertoire and wide use of nanomedicines could be developed for kidney diseases in the near future. Some limitations have slowed the transition of these agents from preclinical studies to clinical trials, however. In this review, we summarize the current knowledge on renal drug-delivery systems and recent advances in renal cell targeting; we also demonstrate their important potential as future paradigm-shifting therapies for kidney diseases.<\/jats:p>","DOI":"10.1093\/ndt\/gfac233","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T23:28:19Z","timestamp":1660087699000},"page":"1385-1396","source":"Crossref","is-referenced-by-count":28,"title":["Targeted nanotherapy for kidney diseases: a comprehensive review"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-1652","authenticated-orcid":false,"given":"Gianmarco","family":"Sabiu","sequence":"first","affiliation":[{"name":"Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]},{"name":"School of Nephrology, University of Milan , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Kasinath","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwook","family":"Jung","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Li","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C","family":"Tsokos","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Abdi","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"2025102312513768000_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.08570814","article-title":"Immunosuppressive medications","volume":"11","author":"Wiseman","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312513768000_bib2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2025102312513768000_bib3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrneph.2016.156","article-title":"Nanomedicines for renal disease: current status and future applications","volume":"12","author":"Kamaly","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"2025102312513768000_bib4","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2215\/CJN.02050309","article-title":"Renal vulnerability to drug toxicity","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312513768000_bib5","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2215\/CJN.00150118","article-title":"Pharmacology behind common drug nephrotoxicities","volume":"13","author":"Perazella","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312513768000_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41578-018-0038-3","article-title":"Transport and interactions of nanoparticles in the kidneys","volume":"3","author":"Du","year":"2018","journal-title":"Nat Rev Mater"},{"key":"2025102312513768000_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.mattod.2013.11.003","article-title":"Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology","volume":"16","author":"Liu","year":"2013","journal-title":"Mater Today"},{"key":"2025102312513768000_bib8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat Mater"},{"key":"2025102312513768000_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s42247-020-00109-x","article-title":"Recent advances in stimuli-responsive drug release and targeting concepts using mesoporous silica nanoparticles","volume":"3","author":"Abdo","year":"2020","journal-title":"Emergent Materials"},{"key":"2025102312513768000_bib10","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.3390\/ijms19103264","article-title":"Nanoparticle-mediated combination therapy: two-in-one approach for cancer","volume":"19","author":"Gurunathan","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2025102312513768000_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discovery"},{"key":"2025102312513768000_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med"},{"key":"2025102312513768000_bib13","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3762\/bjnano.9.98","article-title":"Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations","volume":"9","author":"Jeevanandam","year":"2018","journal-title":"Beilstein J Nanotechnol"},{"key":"2025102312513768000_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release","volume":"133","author":"Gordillo-Galeano","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"2025102312513768000_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"2025102312513768000_bib16","doi-asserted-by":"crossref","first-page":"e10143","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng Transl Med"},{"key":"2025102312513768000_bib17","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"2025102312513768000_bib18","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N Engl J Med"},{"key":"2025102312513768000_bib19","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.3390\/molecules25163731","article-title":"Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology","volume":"25","author":"Zieli\u0144ska","year":"2020","journal-title":"Molecules"},{"key":"2025102312513768000_bib20","doi-asserted-by":"crossref","first-page":"100397","DOI":"10.1016\/j.nanoso.2019.100397","article-title":"Recent developments in functionalized polymer nanoparticles for efficient drug delivery system","volume":"20","author":"Sur","year":"2019","journal-title":"Nano-Structures & Nano-Objects"},{"key":"2025102312513768000_bib21","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.nano.2017.03.002","article-title":"Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy","volume":"13","author":"Caster","year":"2017","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"2025102312513768000_bib22","doi-asserted-by":"crossref","first-page":"1805730","DOI":"10.1002\/adma.201805730","article-title":"Degradability and clearance of inorganic nanoparticles for biomedical applications","volume":"31","author":"Yang","year":"2019","journal-title":"Adv Mater"},{"key":"2025102312513768000_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/nano6040076","article-title":"Multifunctional inorganic nanoparticles: recent progress in thermal therapy and imaging","volume":"6","author":"Cherukula","year":"2016","journal-title":"Nanomaterials"},{"key":"2025102312513768000_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/toxics5040029","article-title":"Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro\/in vivo toxicity evaluation","volume":"5","author":"De Matteis","year":"2017","journal-title":"Toxics"},{"key":"2025102312513768000_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-60761-609-2_3","article-title":"Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting","volume":"624","author":"Greish","year":"2010","journal-title":"Methods Mol Biol"},{"key":"2025102312513768000_bib26","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/cancers11050640","article-title":"Active targeting strategies using biological ligands for nanoparticle drug delivery systems","volume":"11","author":"Yoo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2025102312513768000_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40824-019-0166-x","article-title":"Therapeutic efficacy of nanoparticles and routes of administration","volume":"23","author":"Chenthamara","year":"2019","journal-title":"Biomaterials Research"},{"key":"2025102312513768000_bib28","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/molecules21121719","article-title":"Nanoparticle-Enabled transdermal drug delivery systems for enhanced dose control and tissue targeting","volume":"21","author":"Palmer","year":"2016","journal-title":"Molecules"},{"key":"2025102312513768000_bib29","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.3390\/ijms15045852","article-title":"Nanoparticle-mediated pulmonary drug delivery: a review","volume":"15","author":"Paranjpe","year":"2014","journal-title":"Int J Mol Sci"},{"key":"2025102312513768000_bib30","doi-asserted-by":"crossref","first-page":"119671","DOI":"10.1016\/j.ijpharm.2020.119671","article-title":"Inhaled nanoparticles\u2014an updated review","volume":"587","author":"Praphawatvet","year":"2020","journal-title":"Int J Pharm"},{"key":"2025102312513768000_bib31","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.cgh.2014.06.018","article-title":"Polymeric nanoparticle technologies for oral drug delivery","volume":"12","author":"Pridgen","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025102312513768000_bib32","doi-asserted-by":"crossref","first-page":"104685","DOI":"10.1016\/j.phrs.2020.104685","article-title":"Oral administration of protein nanoparticles: an emerging route to disease treatment","volume":"158","author":"Sadeghi","year":"2020","journal-title":"Pharmacol Res"},{"key":"2025102312513768000_bib33","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1166\/jnn.2018.15766","article-title":"Formation and characterization of protein corona around nanoparticles: a review","volume":"18","author":"Pareek","year":"2018","journal-title":"J Nanosci Nanotechnol"},{"key":"2025102312513768000_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-11-337","article-title":"Kinetic targeting of pegylated liposomal doxorubicin: a new approach to reduce toxicity during chemotherapy (CARL-trial)","volume":"11","author":"Eckes","year":"2011","journal-title":"BMC Cancer"},{"key":"2025102312513768000_bib35","doi-asserted-by":"crossref","first-page":"106678","DOI":"10.1016\/j.vascn.2020.106678","article-title":"Antibodies against polyethylene glycol in human blood: a literature review","volume":"102","author":"Hong","year":"2020","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2025102312513768000_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s42004-020-00369-y","article-title":"Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers","volume":"3","author":"Huckaby","year":"2020","journal-title":"Communications Chemistry"},{"key":"2025102312513768000_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154-155","author":"Kozma","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"2025102312513768000_bib38","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11095-016-1961-x","article-title":"The mystery of antibodies against polyethylene glycol (PEG)\u2014what do we know?","volume":"33","author":"Lubich","year":"2016","journal-title":"Pharm Res"},{"key":"2025102312513768000_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1078\/0171-9335-00363","article-title":"PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles","volume":"83","author":"Mishra","year":"2004","journal-title":"Eur J Cell Biol"},{"key":"2025102312513768000_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \u201cPEG dilemma\u201d in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Deliv"},{"key":"2025102312513768000_bib41","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1103573108","article-title":"Targeting kidney mesangium by nanoparticles of defined size","volume":"108","author":"Choi","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"2025102312513768000_bib42","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.biomaterials.2012.12.043","article-title":"The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes","volume":"34","author":"Fu","year":"2013","journal-title":"Biomaterials"},{"key":"2025102312513768000_bib43","doi-asserted-by":"crossref","first-page":"9597","DOI":"10.1021\/ac801882g","article-title":"In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles","volume":"80","author":"He","year":"2008","journal-title":"Anal Chem"},{"key":"2025102312513768000_bib44","doi-asserted-by":"crossref","first-page":"12572","DOI":"10.1002\/anie.201304465","article-title":"PEGylation and zwitterionization: pros and cons in the renal clearance and tumor targeting of near-IR-emitting gold nanoparticles","volume":"52","author":"Liu","year":"2013","journal-title":"Angew Chem Int Ed"},{"key":"2025102312513768000_bib45","doi-asserted-by":"crossref","first-page":"646708","DOI":"10.3389\/fbioe.2021.646708","article-title":"In vivo protein corona formation: characterizations, effects on engineered nanoparticles\u2019 biobehaviors, and applications","volume":"9","author":"Bai","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"2025102312513768000_bib46","doi-asserted-by":"crossref","first-page":"9664","DOI":"10.1038\/s41598-020-66572-y","article-title":"Controlling evolution of protein corona: a prosperous approach to improve chitosan-based nanoparticle biodistribution and half-life","volume":"10","author":"Tekie","year":"2020","journal-title":"Sci Rep"},{"key":"2025102312513768000_bib47","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"2025102312513768000_bib48","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.biomaterials.2007.12.037","article-title":"Particle size-dependent organ distribution of gold nanoparticles after intravenous administration","volume":"29","author":"De Jong","year":"2008","journal-title":"Biomaterials"},{"key":"2025102312513768000_bib49","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Soo Choi","year":"2007","journal-title":"Nat Biotechnol"},{"key":"2025102312513768000_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nnano.2009.314","article-title":"Design considerations for tumour-targeted nanoparticles","volume":"5","author":"Choi","year":"2010","journal-title":"Nat Nanotechnol"},{"key":"2025102312513768000_bib51","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2147\/IJN.S64301","article-title":"Passing through the renal clearance barrier: toward ultrasmall sizes with stable ligands for potential clinical applications","volume":"9","author":"Zhang","year":"2014","journal-title":"Int J Nanomed"},{"key":"2025102312513768000_bib52","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.ackd.2013.06.003","article-title":"Targeting therapeutics to the glomerulus with nanoparticles","volume":"20","author":"Zuckerman","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"2025102312513768000_bib53","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41467-017-00834-8","article-title":"Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis","volume":"8","author":"Guo","year":"2017","journal-title":"Nat Commun"},{"key":"2025102312513768000_bib54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nnano.2013.309","article-title":"DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination","volume":"9","author":"Chou","year":"2014","journal-title":"Nat Nanotechnol"},{"key":"2025102312513768000_bib55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmat2398","article-title":"Biodegradable luminescent porous silicon nanoparticles for in vivo applications","volume":"8","author":"Park","year":"2009","journal-title":"Nat Mater"},{"key":"2025102312513768000_bib56","doi-asserted-by":"crossref","first-page":"15249","DOI":"10.1039\/C8NR03440K","article-title":"Nanoparticle localization in blood vessels: dependence on fluid shear stress, flow disturbances, and flow-induced changes in endothelial physiology","volume":"10","author":"Gomez-Garcia","year":"2018","journal-title":"Nanoscale"},{"key":"2025102312513768000_bib57","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.apsb.2019.11.012","article-title":"Effect of fluid shear stress on the internalization of kidney-targeted delivery systems in renal tubular epithelial cells","volume":"10","author":"Xu","year":"2020","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"2025102312513768000_bib58","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1002\/adma.201402964","article-title":"Gd-encapsulated carbonaceous dots with efficient renal clearance for magnetic resonance imaging","volume":"26","author":"Chen","year":"2014","journal-title":"Adv Mater"},{"key":"2025102312513768000_bib59","doi-asserted-by":"crossref","first-page":"16114","DOI":"10.1039\/D0TA05183G","article-title":"Challenges and opportunities in the bottom-up mechanochemical synthesis of noble metal nanoparticles","volume":"8","author":"de Oliveira","year":"2020","journal-title":"J Mater Chem A"},{"key":"2025102312513768000_bib60","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/s41467-020-15206-y","article-title":"Exploiting the role of nanoparticle shape in enhancing hydrogel adhesive and mechanical properties","volume":"11","author":"Arno","year":"2020","journal-title":"Nat Commun"},{"key":"2025102312513768000_bib61","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4155\/tde.11.156","article-title":"The shape of things to come: importance of design in nanotechnology for drug delivery","volume":"3","author":"Liu","year":"2012","journal-title":"Ther Deliv"},{"key":"2025102312513768000_bib62","doi-asserted-by":"crossref","first-page":"15350","DOI":"10.1039\/C8NR04042G","article-title":"Influence of particle size and shape on their margination and wall-adhesion: implications in drug delivery vehicle design across nano-to-micro scale","volume":"10","author":"Cooley","year":"2018","journal-title":"Nanoscale"},{"key":"2025102312513768000_bib63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2019.07.026","article-title":"Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions","volume":"309","author":"Da Silva-Candal","year":"2019","journal-title":"J Controlled Release"},{"key":"2025102312513768000_bib64","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jbiomech.2008.03.021","article-title":"The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows","volume":"41","author":"Gentile","year":"2008","journal-title":"J Biomech"},{"key":"2025102312513768000_bib65","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1039\/C8RA00033F","article-title":"The shape effect on polymer nanoparticle transport in a blood vessel","volume":"8","author":"Uhl","year":"2018","journal-title":"RSC Adv"},{"key":"2025102312513768000_bib66","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.1073\/pnas.0913667107","article-title":"Paradoxical glomerular filtration of carbon nanotubes","volume":"107","author":"Ruggiero","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025102312513768000_bib67","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1021\/acsnano.6b03358","article-title":"The effects of extensive glomerular filtration of thin graphene oxide sheets on kidney physiology","volume":"10","author":"Jasim","year":"2016","journal-title":"ACS Nano"},{"key":"2025102312513768000_bib68","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/smll.200800323","article-title":"Carbon-nanotube shape and individualization critical for renal excretion","volume":"4","author":"Lacerda","year":"2008","journal-title":"Small"},{"key":"2025102312513768000_bib69","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s11671-018-2728-6","article-title":"Insight into cellular uptake and intracellular trafficking of nanoparticles","volume":"13","author":"Foroozandeh","year":"2018","journal-title":"Nanoscale Res Lett"},{"key":"2025102312513768000_bib70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ki.2008.260","article-title":"Glomerular filtration: the charge debate charges ahead","volume":"74","author":"Miner","year":"2008","journal-title":"Kidney Int"},{"key":"2025102312513768000_bib71","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Choi","year":"2007","journal-title":"Nat Biotechnol"},{"key":"2025102312513768000_bib72","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/acsnano.5b05066","article-title":"Short- and long-term tracking of anionic ultrasmall nanoparticles in kidney","volume":"10","author":"Liang","year":"2016","journal-title":"ACS Nano"},{"key":"2025102312513768000_bib73","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/smll.201303540","article-title":"Zwitterionic-coated \u201cstealth\u201d nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system","volume":"10","author":"Garc\u00eda","year":"2014","journal-title":"Small"},{"key":"2025102312513768000_bib74","doi-asserted-by":"crossref","first-page":"8162","DOI":"10.1002\/adma.201601101","article-title":"Renal clearable organic nanocarriers for bioimaging and drug delivery","volume":"28","author":"Kang","year":"2016","journal-title":"Adv Mater"},{"key":"2025102312513768000_bib75","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1039\/C1JM14178C","article-title":"Minimizing nonspecific phagocytic uptake of biocompatible gold nanoparticles with mixed charged zwitterionic surface modification","volume":"22","author":"Liu","year":"2012","journal-title":"J Mater Chem"},{"key":"2025102312513768000_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10439-005-8976-5","article-title":"A theoretical model for the margination of particles within blood vessels","volume":"33","author":"Decuzzi","year":"2005","journal-title":"Ann Biomed Eng"},{"key":"2025102312513768000_bib77","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.04.016","article-title":"Improving kidney targeting: the influence of nanoparticle physicochemical properties on kidney interactions","volume":"334","author":"Huang","year":"2021","journal-title":"J Controlled Release"},{"key":"2025102312513768000_bib78","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1002\/anie.201609043","article-title":"Tailoring renal clearance and tumor targeting of ultrasmall metal nanoparticles with particle density","volume":"55","author":"Tang","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"2025102312513768000_bib79","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1021\/nl803405h","article-title":"Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine","volume":"9","author":"Burns","year":"2009","journal-title":"Nano Lett"},{"key":"2025102312513768000_bib80","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1039\/C9FD00091G","article-title":"Ultrasmall silicon nanoparticles as a promising platform for multimodal imaging","volume":"222","author":"Singh","year":"2020","journal-title":"Farad Discuss"},{"key":"2025102312513768000_bib81","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpb.2010.12.029","article-title":"Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration","volume":"77","author":"Hirn","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"2025102312513768000_bib82","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41573-020-0078-4","article-title":"Soluble ligands as drug targets","volume":"19","author":"Attwood","year":"2020","journal-title":"Nat Rev Drug Discovery"},{"key":"2025102312513768000_bib83","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1039\/C8BM01340C","article-title":"Peptide ligand-mediated targeted drug delivery of nanomedicines","volume":"7","author":"Jiang","year":"2019","journal-title":"Biomaterials Science"},{"key":"2025102312513768000_bib84","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1021\/acs.chemrev.7b00013","article-title":"Ligand-targeted drug delivery","volume":"117","author":"Srinivasarao","year":"2017","journal-title":"Chem Rev"},{"key":"2025102312513768000_bib85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/mol.107.034140","article-title":"Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium","volume":"72","author":"Asgeirsd\u00f3ttir","year":"2007","journal-title":"Mol Pharmacol"},{"key":"2025102312513768000_bib86","doi-asserted-by":"crossref","first-page":"F554","DOI":"10.1152\/ajprenal.00391.2007","article-title":"Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes","volume":"294","author":"\u00c1sgeirsd\u00f3ttir","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025102312513768000_bib87","doi-asserted-by":"crossref","first-page":"eaam6764","DOI":"10.1126\/scitranslmed.aam6764","article-title":"Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys","volume":"9","author":"Tietjen","year":"2017","journal-title":"Sci Transl Med"},{"key":"2025102312513768000_bib88","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1002\/art.24026","article-title":"Anti-alpha8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus","volume":"58","author":"Scindia","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025102312513768000_bib89","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/jpet.110.176222","article-title":"Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis","volume":"337","author":"Suana","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"2025102312513768000_bib90","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/nat.2014.0505","article-title":"siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA","volume":"25","author":"Zuckerman","year":"2015","journal-title":"Nucleic Acid Ther"},{"key":"2025102312513768000_bib91","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.ekir.2020.02.391","article-title":"Sat-369 novel glomerular targeted nanoparticles for treatment of lupus nephropathy","volume":"5","author":"Liu","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2025102312513768000_bib92","doi-asserted-by":"crossref","first-page":"749.743","DOI":"10.1096\/fasebj.2019.33.1_supplement.749.3","article-title":"Development of a glomerular specific targeted nanoparticles for lupus nephritis","volume":"33","author":"Wei","year":"2019","journal-title":"FASEB J"},{"key":"2025102312513768000_bib93","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1021\/acsomega.6b00423","article-title":"Polymer nanoparticle engineering for podocyte repair: from in vitro models to new nanotherapeutics in kidney diseases","volume":"2","author":"Colombo","year":"2017","journal-title":"ACS Omega"},{"key":"2025102312513768000_bib94","doi-asserted-by":"crossref","first-page":"e0138870","DOI":"10.1371\/journal.pone.0138870","article-title":"Targeting rapamycin to podocytes using a vascular cell adhesion molecule-1 (VCAM-1)-Harnessed SAINT-based lipid carrier system","volume":"10","author":"Visweswaran","year":"2015","journal-title":"PLoS One"},{"key":"2025102312513768000_bib95","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3892\/ijmm.2017.2902","article-title":"Albumin-based nanoparticles as methylprednisolone carriers for targeted delivery towards the neonatal Fc receptor in glomerular podocytes","volume":"39","author":"Wu","year":"2017","journal-title":"Int J Mol Med"},{"key":"2025102312513768000_bib96","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1038\/s41598-019-39842-7","article-title":"Long term safety of targeted internalization of cell penetrating peptide crotamine into renal proximal tubular epithelial cells in vivo","volume":"9","author":"Campeiro","year":"2019","journal-title":"Sci Rep"},{"key":"2025102312513768000_bib97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.11.019","article-title":"Folate-dactolisib conjugates for targeting tubular cells in polycystic kidneys","volume":"293","author":"Shi","year":"2019","journal-title":"J Controlled Release"},{"key":"2025102312513768000_bib98","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/acs.bioconjchem.6b00057","article-title":"Renal targeting: peptide-based drug delivery to proximal tubule cells","volume":"27","author":"Wischnjow","year":"2016","journal-title":"Bioconjugate Chem"},{"key":"2025102312513768000_bib99","doi-asserted-by":"crossref","first-page":"053406","DOI":"10.1063\/1.4978381","article-title":"Physiological stability and renal clearance of ultrasmall zwitterionic gold nanoparticles: ligand length matters","volume":"5","author":"Ning","year":"2017","journal-title":"APL Materials"},{"key":"2025102312513768000_bib100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","article-title":"Endothelium structure and function in kidney health and disease","volume":"15","author":"Jourde-Chiche","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2025102312513768000_bib101","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2015.162","article-title":"The glycocalyx\u2014linking albuminuria with renal and cardiovascular disease","volume":"11","author":"Rabelink","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"2025102312513768000_bib102","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3390\/jcm9082359","article-title":"Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update","volume":"9","author":"Roumeliotis","year":"2020","journal-title":"J Clin Med"},{"key":"2025102312513768000_bib103","doi-asserted-by":"crossref","first-page":"14361","DOI":"10.1038\/ncomms14361","article-title":"The molecular basis of endothelial cell plasticity","volume":"8","author":"Dejana","year":"2017","journal-title":"Nat Commun"},{"key":"2025102312513768000_bib104","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.kint.2017.09.029","article-title":"Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease","volume":"93","author":"Chade","year":"2018","journal-title":"Kidney Int"},{"key":"2025102312513768000_bib105","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.kint.2018.12.022","article-title":"The TNF-derived TIP peptide activates the epithelial sodium channel and ameliorates experimental nephrotoxic serum nephritis","volume":"95","author":"Madaio","year":"2019","journal-title":"Kidney Int"},{"key":"2025102312513768000_bib106","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41581-020-0329-y","article-title":"Complexities of the glomerular basement membrane","volume":"17","author":"Naylor","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"2025102312513768000_bib107","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1681\/ASN.2010020199","article-title":"Imaging of the porous ultrastructure of the glomerular epithelial filtration slit","volume":"21","author":"Gagliardini","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2025102312513768000_bib108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/002215549804600104","article-title":"Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane","volume":"46","author":"Groffen","year":"1998","journal-title":"J Histochem Cytochem"},{"key":"2025102312513768000_bib109","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.yexcr.2012.02.031","article-title":"The glomerular basement membrane","volume":"318","author":"Miner","year":"2012","journal-title":"Exp Cell Res"},{"key":"2025102312513768000_bib110","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJM197804132981507","article-title":"Molecular basis of proteinuria of glomerular origin","volume":"298","author":"Brenner","year":"1978","journal-title":"N Engl J Med"},{"key":"2025102312513768000_bib111","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/ndt\/gfn758","article-title":"Glomerular filtration is normal in the absence of both agrin and perlecan\u2013heparan sulfate from the glomerular basement membrane","volume":"24","author":"Goldberg","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312513768000_bib112","doi-asserted-by":"crossref","first-page":"F1211","DOI":"10.1152\/ajprenal.00126.2019","article-title":"Glomerular permeability is not affected by heparan sulfate glycosaminoglycan deficiency in zebrafish embryos","volume":"317","author":"Khalil","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025102312513768000_bib113","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.ki.5002706","article-title":"Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria","volume":"73","author":"van den Hoven","year":"2008","journal-title":"Kidney Int"},{"key":"2025102312513768000_bib114","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1073\/pnas.1616457114","article-title":"Permeation of macromolecules into the renal glomerular basement membrane and capture by the tubules","volume":"114","author":"Lawrence","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025102312513768000_bib115","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1073\/pnas.1200718109","article-title":"Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane","volume":"109","author":"Zuckerman","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025102312513768000_bib116","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","article-title":"IgA nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025102312513768000_bib117","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1159\/000516984","article-title":"Membranous nephropathy: it is time to go back to the future","volume":"145","author":"Sabiu","year":"2021","journal-title":"Nephron"},{"key":"2025102312513768000_bib118","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312513768000_bib119","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025102312513768000_bib120","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/01.ASN.0000065640.77499.D7","article-title":"Extracellular matrix metabolism in diabetic nephropathy","volume":"14","author":"Mason","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2025102312513768000_bib121","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.addr.2010.08.011","article-title":"Mesangial pathology in glomerular disease: targets for therapeutic intervention","volume":"62","author":"Scindia","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"2025102312513768000_bib122","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nep.13451","article-title":"Glomerular mesangial cell and podocyte injuries in diabetic nephropathy","volume":"23","author":"Tung","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"2025102312513768000_bib123","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2215\/CJN.13791215","article-title":"The players: cells involved in glomerular disease","volume":"11","author":"Kitching","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312513768000_bib124","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-981-13-8871-2_9","article-title":"Mesangial cells and renal fibrosis","volume":"1165","author":"Zhao","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"2025102312513768000_bib125","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1103573108","article-title":"Targeting kidney mesangium by nanoparticles of defined size","volume":"108","author":"Choi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025102312513768000_bib126","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1586\/1744666X.2015.1087314","article-title":"Mycophenolate mofetil for lupus nephritis: an update","volume":"11","author":"Mok","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"2025102312513768000_bib127","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ki.2009.499","article-title":"Long-term study of mycophenolate mofetil treatment in IgA nephropathy","volume":"77","author":"Tang","year":"2010","journal-title":"Kidney Int"},{"key":"2025102312513768000_bib128","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.transproceed.2009.09.017","article-title":"Balancing efficacy and toxicity of kidney transplant immunosuppression","volume":"41","author":"Naesens","year":"2009","journal-title":"Transplant Proc"},{"issue":"suppl 1","key":"2025102312513768000_bib129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000481633","article-title":"A review of podocyte biology","volume":"47","author":"Garg","year":"2018","journal-title":"Am J Nephrol"},{"key":"2025102312513768000_bib130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2012070734","article-title":"The treatment of minimal change disease in adults","volume":"24","author":"Hogan","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2025102312513768000_bib131","doi-asserted-by":"crossref","first-page":"101323","DOI":"10.11131\/2018\/101323","article-title":"The role of glucocorticoid receptors in podocytes and nephrotic syndrome","volume":"5","author":"Zhao","year":"2018","journal-title":"Nucl Receptor Res"},{"key":"2025102312513768000_bib132","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2025102312513768000_bib133","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2017.04.005","article-title":"Ultrasmall polymeric nanocarriers for drug delivery to podocytes in kidney glomerulus","volume":"255","author":"Bruni","year":"2017","journal-title":"J Controlled Release"},{"key":"2025102312513768000_bib134","doi-asserted-by":"crossref","first-page":"ra39","DOI":"10.1126\/scisignal.2000678","article-title":"C-mip impairs podocyte proximal signaling and induces heavy proteinuria","volume":"3","author":"Zhang","year":"2010","journal-title":"Sci Signal"},{"key":"2025102312513768000_bib135","doi-asserted-by":"crossref","first-page":"126475","DOI":"10.1016\/j.cej.2020.126475","article-title":"Kidney-targeted drug delivery systems based on tailor-made nanocapsules","volume":"404","author":"Oniszczuk","year":"2021","journal-title":"Chem Eng J"},{"key":"2025102312513768000_bib136","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1172\/JCI99507","article-title":"CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease","volume":"128","author":"Maeda","year":"2018","journal-title":"J Clin Invest"},{"key":"2025102312513768000_bib137","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrneph.2017.52","article-title":"The systemic nature of CKD","volume":"13","author":"Zoccali","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2025102312513768000_bib138","doi-asserted-by":"crossref","first-page":"331ra339","DOI":"10.1126\/scitranslmed.aac9647","article-title":"Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury","volume":"8","author":"Alidori","year":"2016","journal-title":"Sci Transl Med"},{"key":"2025102312513768000_bib139","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1021\/acsnano.5b00428","article-title":"Characterizing the interactions of organic nanoparticles with renal epithelial cells in vivo","volume":"9","author":"Nair","year":"2015","journal-title":"ACS Nano"},{"key":"2025102312513768000_bib140","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1007\/s12274-018-2100-2","article-title":"Design and in vivo characterization of kidney-targeting multimodal micelles for renal drug delivery","volume":"11","author":"Wang","year":"2018","journal-title":"Nano Res"},{"key":"2025102312513768000_bib141","doi-asserted-by":"crossref","first-page":"100990","DOI":"10.1016\/j.nantod.2020.100990","article-title":"Selective trafficking of light chain-conjugated nanoparticles to the kidney and renal cell carcinoma","volume":"35","author":"Ordikhani","year":"2020","journal-title":"Nano Today"},{"key":"2025102312513768000_bib142","doi-asserted-by":"crossref","first-page":"8255","DOI":"10.3390\/ijms21218255","article-title":"Peritubular capillary rarefaction: an underappreciated regulator of CKD progression","volume":"21","author":"Kida","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025102312513768000_bib143","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/HYPERTENSIONAHA.117.09843","article-title":"Selective nanoparticle targeting of the renal tubules","volume":"71","author":"Williams","year":"2018","journal-title":"Hypertension"},{"key":"2025102312513768000_bib144","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.kint.2020.01.036","article-title":"Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury","volume":"98","author":"Han","year":"2020","journal-title":"Kidney Int"},{"key":"2025102312513768000_bib145","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"2025102312513768000_bib146","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1681\/ASN.2012020181","article-title":"Rituximab in idiopathic membranous nephropathy","volume":"23","author":"Ruggenenti","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2025102312513768000_bib147","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1517\/14712598.2015.1045870","article-title":"Monoclonal antibodies for renal diseases: current concepts and ongoing treatments","volume":"15","author":"Santoro","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"2025102312513768000_bib148","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2016.02.006","article-title":"Extracellular vesicles for drug delivery","volume":"106","author":"Vader","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"2025102312513768000_bib149","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1681\/ASN.2008070798","article-title":"Mesenchymal stem cell-derived microvesicles protect against acute tubular injury","volume":"20","author":"Bruno","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2025102312513768000_bib150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.kint.2016.12.023","article-title":"Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation","volume":"92","author":"Eirin","year":"2017","journal-title":"Kidney Int"},{"key":"2025102312513768000_bib151","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1111\/jcmm.13249","article-title":"Perfusion of isolated rat kidney with mesenchymal stromal cells\/extracellular vesicles prevents ischaemic injury","volume":"21","author":"Gregorini","year":"2017","journal-title":"J Cell Mol Med"},{"key":"2025102312513768000_bib152","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40824-016-0068-0","article-title":"Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases","volume":"20","author":"Nassar","year":"2016","journal-title":"Biomater Res"},{"key":"2025102312513768000_bib153","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41581-022-00586-9","article-title":"Extracellular vesicles in kidney disease","volume":"18","author":"Grange","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"2025102312513768000_bib154","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/10717544.2020.1748758","article-title":"Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source","volume":"27","author":"Meng","year":"2020","journal-title":"Drug Deliv"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfac233\/47069730\/gfac233.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/6\/1385\/50463116\/gfac233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/6\/1385\/50463116\/gfac233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:53:17Z","timestamp":1761238397000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/38\/6\/1385\/6659198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":154,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,8,9]]},"published-print":{"date-parts":[[2023,5,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfac233","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2022,8,9]]}}}